News

Learning from microalgae as ‘biofactories’

In a newly published research, former members of the Price lab Saheed Imam and Sascha Schäuble, in collaboration with the Baliga lab, share discoveries from their studies of Chlamydomonas reinhardtiiChlamy for short. What follows is a short excerpt:

To the casual observer, algae may appear to be a nuisance. But for researchers, photosynthetic microalgae and other microbes have the potential to become sustainable biofactories that can economically produce renewable biofuels and a wide variety of other valuable commodities. One such group of microalgae is Chlamydomonas reinhardtiiChlamy for short. In an effort to better understand the gene regulatory and metabolic networks of this single-celled alga, researchers at Institute for Systems Biology studied the changes in Chlamy’s genetics and metabolism that cause them to capture and store carbon dioxide.

Read the full article on the ISB website…

Related Articles

  • Town Hall Seattle panel

    Expert Panel Discusses 21st Century Health at Town Hall Seattle Event

    In a public panel discussion put on by Town Hall Seattle and ISB, legendary biologist Dr. Lee Hood, PSJH Chief Clinical Officer Dr. Amy Compton-Phillips, and PATH’s Program Leader of Diagnostics Tala de los Santos addressed the promise — and challenges — of implementing and practicing 21st century health care.

  • Dr. Jim Heath Takes Helm of ISB, Looks Toward the Future

    Jim Heath took over as president of Institute for Systems Biology on January 1. To fully appreciate Heath’s relationship with ISB, you have to go back to its early days – shortly after the research organization was founded in 2000.

  • Institute for Systems Biology recruits technology pioneer James Heath as President

    The Institute for Systems Biology has named James Heath, PhD, as its new president, effective January 2018. Heath is widely recognized as one of the world’s most accomplished scientists, working on fundamental problems at the interface of the chemical, physical, biological, and biomedical sciences, with focus areas of molecular biotechnologies and oncology. ISB’s co-founder and president Lee Hood, MD, PhD, was appointed senior vice president and chief science officer at…

Show More Articles